Patent: 9,969,805
✉ Email this page to a colleague
Summary for Patent: 9,969,805
Title: | Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
Abstract: | The present invention relates to amino acid sequences and Nanobodies that are directed against Epidermal Growth Factor Receptor 2 (HER2), as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. |
Inventor(s): | Revets; Hilde Adi Pierrette (Meise, BE), Boutton; Carlo (Wielsbeke, BE), Hoogenboom; Hendricus Renerus Jacobus Mattheus (Maastricht, NL) |
Assignee: | Ablynx N.V. (Ghent-Zwijnaarde, BE) |
Application Number: | 14/592,022 |
Patent Claims: | see list of patent claims |
Details for Patent 9,969,805
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2027-11-27 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2027-11-27 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2027-11-27 |
Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2027-11-27 |
Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 02/17/1995 | ⤷ Try a Trial | 2027-11-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |